Follow the NYMOX PHARMACEUTICAL CORP stock price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €19k. The latest transaction was disclosed on 26 June 2023 (Acquisition). Among the most active insiders: Robinson James George. The full history is openly available.
15
Insider Decl.
n/a
Thresholds
€32,792
15 ops.
Buy Volume
n/a
n/a
Sell Volume
20Σ signal
Buys €32,792n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
NYMOX PHARMACEUTICAL CORP es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades relacionadas con la edad. Cotiza en el NASDAQ con el símbolo NYMX.